These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35445132)

  • 1. Exploration on the Effect of Nonselective
    Mao G; Li C; Wang H; Jv YH; Zhang Y; Liu L
    Biomed Res Int; 2022; 2022():7922906. PubMed ID: 35445132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal resting heart rate and ascites-related death in patients with cirrhosis and ascites using nonselective beta-blockers (ORCA).
    Mingpun W; Sobhonslidsuk A; Chumnumwat S
    Clin Transl Sci; 2024 Jan; 17(1):e13681. PubMed ID: 37950532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications.
    Bultas AC; Teshome B; Richter SK; Schafers S; Cooke E; Call WB
    Ann Pharmacother; 2020 Jun; 54(6):583-593. PubMed ID: 31810371
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers and cirrhosis: Striking the right balance.
    Cromer M; Wilcox CM; Shoreibah M
    Am J Med Sci; 2024 Apr; 367(4):228-234. PubMed ID: 38262558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carvedilol and propranolol for primary prophylaxis of esophageal variceal bleed in cirrhotic patients.
    Muhammad Farooq Hanif -; Raja Omer Fiaz -; Muhammad Adnan Iqbal -; Aneeza Ilyas -; Maria -; Khalid Mahmud Khan -; Nooman Gilani -
    Pak J Pharm Sci; 2023 May; 36(3):857-862. PubMed ID: 37580935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.
    Villanueva C; Sapena V; Lo GH; Seo YS; Shah HA; Singh V; Tripathi D; Schepke M; Gheorghe C; Bonilha DQ; Jutabha R; Wang HM; Rodrigues SG; Brujats A; Lee HA; Azam Z; Kumar P; Hayes PC; Sauerbruch T; Chen WC; Iacob S; Libera ED; Jensen DM; Alvarado E; Torres F; Bosch J;
    Aliment Pharmacol Ther; 2024 Feb; 59(3):306-321. PubMed ID: 38108646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
    Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis.
    Snoga JL; Lusk KA; Attridge RT; Attridge RL
    Ann Pharmacother; 2020 Apr; 54(4):322-330. PubMed ID: 31701773
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
    La Mura V; Tosetti G; Primignani M; Salerno F
    World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-blockers in advanced cirrhosis: More friend than enemy.
    Yoon KT; Liu H; Lee SS
    Clin Mol Hepatol; 2021 Jul; 27(3):425-436. PubMed ID: 33317244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
    Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.
    Xu X; Guo X; De Stefano V; Silva-Junior G; Goyal H; Bai Z; Zhao Q; Qi X
    Hepatol Int; 2019 Jul; 13(4):468-481. PubMed ID: 31175581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding.
    Drastich P; Lata J; Petrtyl J; Bruha R; Prochazka V; Vanasek T; Zdenek P; Skibova J; Hucl T; Spicak J
    Ann Hepatol; 2011; 10(2):142-9. PubMed ID: 21502675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
    Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY
    J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.
    Bossen L; Krag A; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Jun; 63(6):1968-76. PubMed ID: 26599983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.